|
sars-cov-2 |
16 |
|
covid-19 |
14 |
|
coronavirus |
11 |
|
asymptomatic |
8 |
|
conjunctiva |
8 |
|
rt-pcr |
8 |
|
shedding |
8 |
|
covid19 |
7 |
|
diagnosis |
7 |
|
pandemic |
7 |
|
pathogenesis |
7 |
|
phylodynamic |
7 |
|
phylogenetic |
7 |
|
saliva |
7 |
|
screening |
7 |
|
viral genome |
7 |
|
ace2 |
6 |
|
autoantibody |
6 |
|
covid-19 vaccine |
6 |
|
enzymatic immunoassay |
6 |
|
molecular epidemiology |
6 |
|
adenosine deaminase |
5 |
|
antifungal susceptibility |
5 |
|
ccl22 |
5 |
|
covid-19 severity |
5 |
|
molecular identification |
5 |
|
myeloperoxidase |
5 |
|
nasopharyngeal specimen |
5 |
|
non-aspergillus |
5 |
|
non-dermatophyte |
5 |
|
onychomycosis |
5 |
|
alphacoronavirus |
4 |
|
bat |
4 |
|
betacoronavirus |
4 |
|
epidemiology |
4 |
|
global |
4 |
|
host |
4 |
|
interspecies transmission |
4 |
|
acinetobacter baumannii |
3 |
|
air |
3 |
|
bacterium |
3 |
|
beta-lactamases |
3 |
|
biologic |
3 |
|
colorimetric assay |
3 |
|
ctx-m |
3 |
|
cytokine antagonist |
3 |
|
dirofilaria hongkongensis |
3 |
|
enterobacteriaceae |
3 |
|
evolution |
3 |
|
extended-spectrum beta-lactamases |
3 |
|
fungal infection |
3 |
|
fungus |
3 |
|
genomics |
3 |
|
human |
3 |
|
immune checkpoint |
3 |
|
immunochromatographic assay |
3 |
|
infectious disease |
3 |
|
interleukin |
3 |
|
keywords zoonotic infections |
3 |
|
multidrug-resistant |
3 |
|
nosocomial |
3 |
|
novel microbe |
3 |
|
phylogeny |
3 |
|
recurrent |
3 |
|
sars coronavirus |
3 |
|
sequencing |
3 |
|
subcutaneous |
3 |
|
tumor necrosis factor |
3 |
|
urinary tract infections |
3 |
|
virulence determinants |
3 |
|
virus |
3 |
|
zoonosis |
3 |
|
autoimmune diseases |
2 |
|
biologics |
2 |
|
cryptococcosis |
2 |
|
h58 |
2 |
|
hematology |
2 |
|
hong kong |
2 |
|
salmonella typhi |
2 |
|
transplant |
2 |
|
typhoid fever |
2 |
|
xdr |
2 |
